亚太药业 (002370.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(亚太药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 84,902,518.00109,220,753.13112,712,517.95118,785,496.8080,720,398.8697,553,413.11123,584,310.47
 营业收入(元) 84,902,518.00109,220,753.13112,712,517.95118,785,496.8080,720,398.8697,553,413.11123,584,310.47
二、营业总成本(元) 99,603,340.93113,623,045.97114,454,069.55130,781,677.93104,848,363.37122,455,731.10126,382,479.22
 营业成本(元) 60,151,329.6575,391,747.0875,876,115.3885,729,843.4458,434,530.7864,240,164.2877,241,425.47
 研发费用(元) 3,107,176.022,502,505.174,643,430.605,896,916.577,873,119.753,416,513.314,608,303.89
 营业税金及附加(元) 1,687,238.721,747,466.951,216,517.101,108,452.821,592,230.001,831,701.281,606,341.73
 销售费用(元) 14,569,153.6515,222,019.5314,316,311.0019,768,191.5112,287,408.1724,957,304.0519,599,947.10
 管理费用(元) 15,150,782.9812,489,568.7513,198,118.3112,294,545.2716,807,511.9018,622,129.1913,122,663.49
 财务费用(元) 4,937,659.916,269,738.495,203,577.165,983,728.327,853,562.779,387,918.9910,203,797.54
  其中:利息费用(元) 8,407,088.959,037,465.958,929,217.049,323,447.1411,748,887.5613,247,392.7513,138,103.04
  其中:利息收入(元) 547,850.002,769,591.743,730,714.883,340,049.623,897,496.883,856,703.552,955,068.01
 资产减值损失(元) --994,816.50-872,535.60-2,167,495.85--2,581,486.65-2,816,833.33
 信用减值损失(元) -64,580.45-254,367.11402,786.94318,677.21-177,823.41-467,413.62-301,550.54
三、其他经营收益
 加:公允价值变动收益(元) 3,811,413.48-1,371,865.33-1,393,706.46-1,776,187.243,518,617.35-3,354,579.483,391,937.73
 加:投资收益(元) 1,170,519.49---37,712.99634,886.48--
 资产处置收益(元) ---381,122.85---
 其他收益(元) 1,413,188.10715,155.47397,564.041,116,462.092,148,739.59675,063.54415,941.46
四、营业利润(元) -8,370,282.318,375,139.26-3,207,442.68-14,161,315.06-18,003,544.50-29,179,757.40-2,108,673.43
 加:营业外收入(元) 7,290.00---143,472.7525,200.00--
 减:营业外支出(元) ----947,329.00-1,021,050.841,390.00
五、利润总额(元) -8,362,992.318,267,780.77-3,207,442.68-13,357,458.81-17,978,344.5021,882,189.16-2,110,063.43
 减:所得税费用(元) 571,712.02-205,779.80-209,055.97-220,107.98527,792.60-503,186.94508,790.66
六、净利润(元) -8,934,704.338,473,560.57-2,998,386.71-13,137,350.83-18,506,137.1022,385,376.10-2,618,854.09
(一)按经营持续性分类
  持续经营净利润(元) -8,934,704.338,473,560.57-2,998,386.71-13,137,350.83-18,506,137.10--
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -8,934,704.338,473,560.57-2,998,386.71-13,137,350.83-18,506,137.1022,385,376.10-2,618,854.09
 扣除非经常性损益后的净利润(元) -14,765,403.38-5,615,360.25-2,211,300.26-10,770,970.38-24,343,761.60-27,984,352.02-5,845,445.18
七、每股收益
 一、基本每股收益(元) -0.020.01--0.02-0.040.04-
 二、稀释每股收益(元) -0.020.01--0.02-0.040.04-
九、综合收益总额(元) -8,934,704.339,071,941.76-2,998,386.71-13,137,350.83-18,506,137.1022,385,376.10-2,618,854.09
 归属于母公司所有者的综合收益总额(元) -8,934,704.339,071,941.76-2,998,386.71-13,137,350.83-18,506,137.1022,385,376.10-2,618,854.09
公告日期 2024-10-312024-08-242024-04-272024-03-302023-10-282023-08-262023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院